LEVER Trial: Levonorgestrel Intrauterine Device Alone or in Combination with an mTORC1 Inhibitor to Overcome Progesterone Resistance in Atypical Hyperplasia or Stage Ia Grade 1 Endometrioid Endometrial Cancer
Year: 2021
Type: article
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3191559914
